tiprankstipranks
Trending News
More News >
Quantum-Si Incorporated (QSI)
NASDAQ:QSI
US Market

Quantum-Si (QSI) Earnings Dates, Call Summary & Reports

Compare
1,828 Followers

Earnings Data

Report Date
May 07, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.11
Last Year’s EPS
-0.11
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presents a mixed but deliberate narrative: strong technical progress on Proteus, meaningful product and scientific milestones, a successful placement program and a healthy cash position that supports execution. These positives are tempered by very low near-term revenue, Q4 margin compression, significant GAAP charges and the need to demonstrate commercial traction and reliable manufacturing for Proteus. Management frames 2026 as a planned transition year prioritizing long-term platform value over near-term revenue.
Company Guidance
Management guided 2026 as a deliberate transition year, forecasting total revenue of approximately $1.0M (driven largely by consumables and services), adjusted operating expenses of $98M or less (adjusted OpEx excludes stock‑based compensation), and total cash usage of $93M or less; they closed 2025 with $215.8M in cash, cash equivalents and marketable securities (supporting operations into Q2 2028), expect a >25% increase in consumable kits run year‑over‑year, plan a modest inventory build for commercial readiness, and reiterated a Proteus launch by end‑2026 with a $425,000 list price; for context, Q4 2025 revenue was $0.451M (Q4 gross margin 27%), FY2025 revenue was $2.4M (FY gross margin 47%), Q4 GAAP OpEx was $21.2M (adjusted $18.3M) and FY GAAP OpEx was $117.3M (adjusted $86.3M), the company has placed 17 new customers via its placement program, expects very limited Platinum Pro capital sales in 2026 (including customer upgrade credits that can defer near‑term revenue), and plans adjusted spending to finish Proteus development while preserving financial flexibility.
Strong Balance Sheet and Runway
Cash, cash equivalents and marketable securities of $215.8M as of 12/31/2025, providing a runway into Q2 2028 and supporting planned Proteus development and operations.
Progress on Proteus Development and Commercial Plan
Prototype Proteus exceeded first-generation performance across key metrics (demonstrated at Nov 2025 Investor Day); list price announced at $425,000 to aid customer budgeting and channel planning for an end-of-2026 launch.
Operational Cost Discipline
Adjusted operating expenses decreased year-over-year: Q4 adjusted OpEx $18.3M vs $26.7M prior Q4 (down ~31.5%); full-year adjusted OpEx $86.3M vs $99.0M in 2024 (down ~12.8%), reflecting targeted resource allocation toward Proteus.
Consumable Utilization Momentum and Placement Program
Placement program secured 17 new customers; management expects >25% increase in number of consumable kits run in 2026, driving recurring consumable revenue even with modest capital sales.
Scientific Validation and Publication Pipeline
Five manuscripts submitted in 2025 and three new manuscripts released (publication or preprint) in the first two months of 2026, including notable use-cases (clinical proteomics for hemoglobinopathies and rapid pathogen/toxin detection).
Product and Reagent Innovations
Launched version 4 sequencing kit and 24 barcodes (Q3 2025) and version 3 library prep kit (Q4 2025); version 3 kit enables sequencing with as little as 1–2 ng protein (over 100-fold reduction in input vs prior kit).

Quantum-Si (QSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

QSI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 2026
2026 (Q1)
-0.10 / -
-0.11
Mar 03, 2026
2025 (Q4)
-0.12 / -0.08
-0.2365.22% (+0.15)
Nov 05, 2025
2025 (Q3)
-0.13 / -0.17
-0.185.56% (<+0.01)
Aug 05, 2025
2025 (Q2)
-0.14 / -0.16
-0.160.00% (0.00)
May 15, 2025
2025 (Q1)
-0.15 / -0.11
-0.1421.43% (+0.03)
Mar 03, 2025
2024 (Q4)
-0.18 / -0.23
-0.16-43.75% (-0.07)
Nov 12, 2024
2024 (Q3)
-0.20 / -0.18
-0.17-5.88% (>-0.01)
Aug 07, 2024
2024 (Q2)
-0.18 / -0.16
-0.1811.11% (+0.02)
May 09, 2024
2024 (Q1)
-0.20 / -0.14
-0.1717.65% (+0.03)
Feb 29, 2024
2023 (Q4)
-0.17 / -0.16
-0.2433.33% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

QSI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 03, 2026
$0.95$0.91-4.01%
Nov 05, 2025
$1.80$1.65-8.33%
Aug 05, 2025
$1.44$1.37-4.86%
May 15, 2025
$1.48$1.480.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quantum-Si Incorporated (QSI) report earnings?
Quantum-Si Incorporated (QSI) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
    What is Quantum-Si Incorporated (QSI) earnings time?
    Quantum-Si Incorporated (QSI) earnings time is at May 07, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is QSI EPS forecast?
          QSI EPS forecast for the fiscal quarter 2026 (Q1) is -0.11.